AbbVie: Consideration For Pharmacyclics To Consist Of $152.25 & 1.6639 Shares

(RTTNews) - AbbVie (ABBV) announced the per share offer consideration amounts pursuant to its offer to acquire each outstanding share of common stock of Pharmacyclics, Inc. for a mix of cash and AbbVie common stock. The mixed consideration will consist of $152.25 in cash and 1.6639 shares of AbbVie common stock and, subject to proration, the all-stock consideration will consist of 3.9879 shares of AbbVie common stock.

AbbVie currently expects that the exchange offer will expire on May 22, 2015. The company noted that, if the exchange offer is extended, AbbVie will recalculate the offer consideration based on the extended expiration date of the offer.